Financhill
Back

Monopar Therapeutics, Inc. Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

Monopar Therapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 72.35 Sell
20-day SMA: 78.65 Sell
50-day SMA: 81.47 Sell
200-day SMA: 52.32 Buy
8-day EMA: 71.44 Sell
20-day EMA: 75.9 Sell
50-day EMA: 76.79 Sell
200-day EMA: 56.68 Buy

Monopar Therapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.61 Sell
Relative Strength Index (14 RSI): 37.25 Sell
Chaikin Money Flow: 166161 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (72.18 - 85.74) Sell
Bollinger Bands (100): (45.57 - 89.21) Buy

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Monopar Therapeutics, Inc. Stock

Is Monopar Therapeutics, Inc. Stock a Buy?

MNPR Technical Analysis vs Fundamental Analysis

Sell
34
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy or a Sell?

Monopar Therapeutics, Inc. Stock Info

Market Cap:
458.6M
Price in USD:
68.63
Share Volume:
522.6K

Monopar Therapeutics, Inc. 52-Week Range

52-Week High:
105.00
52-Week Low:
21.00
Sell
34
Monopar Therapeutics, Inc. (MNPR) is a Sell

Monopar Therapeutics, Inc. Share Price Forecast

Is Monopar Therapeutics, Inc. Stock a Buy?

Fundamental Analysis of Monopar Therapeutics, Inc.

Is Monopar Therapeutics, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Technical Analysis of Monopar Therapeutics, Inc.

Should I short Monopar Therapeutics, Inc. stock?

* Monopar Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.